Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Tetsuhiko Taira
Drastic Initial Response and Subsequent Response to Two ALK Inhibitors in a Patient With a Highly Aggressive ALK-rearranged Inflammatory Myofibroblastic Tumor Arising in the Pleural Cavity
Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Prognostic Significance of Diabetes Mellitus in Locally Advanced Non-Small Cell Lung Cancer
BMC Cancer
Cancer Research
Oncology
Genetics
Related publications
Complete Pathological Response to Crizotinib in a Patient With ALK-rearranged Lung Adenocarcinoma
Clinical Lung Cancer
Cancer Research
Oncology
Respiratory Medicine
Pulmonary
Variable Response to ALK Inhibitors in NSCLC With a Novel MYT1L-ALK Fusion
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Partial Response to Chemotherapy in a Patient With Retroperitoneal Inflammatory Myofibroblastic Tumor
Molecular and Clinical Oncology
Cancer Research
Oncology
TPM3-ALK and TPM4-ALK Oncogenes in Inflammatory Myofibroblastic Tumors
American Journal of Pathology
Forensic Medicine
Pathology
P2.17-001 Pulmonary Inflammatory Myofibroblastic Tumor With TPM4-ALK Translocation
Journal of Thoracic Oncology
Medicine
Oncology
Respiratory Medicine
Pulmonary
Carcinoma of Unknown Primary With EML4‐ALK Fusion Response to ALK Inhibitors
Oncologist
Cancer Research
Medicine
Oncology
ALK Inhibition in Two Emblematic Cases of Pediatric Inflammatory Myofibroblastic Tumor: Efficacy and Side Effects
Pediatric Blood and Cancer
Oncology
Child Health
Hematology
Perinatology
Medicine
Pediatrics
Molecular Mechanisms of Resistance to First- And Second-Generation ALK Inhibitors in ALK-rearranged Lung Cancer
European Journal of Cancer
Cancer Research
Oncology
Dramatic Response to Alectinib in a Lung Cancer Patient With a Novel VKORC1L1-ALK Fusion and an Acquired ALK T1151K Mutation
Lung Cancer: Targets and Therapy
Oncology
